, Singapore

A taste of its own medicine: Singapore banks on pharmaceuticals to boost ailing exports

We're sorry, tech producers.

Singapore’s increased capacity to produce pharmaceutical drugs has boosted exports to the US and Europe, despite Singapore’s lackluster non-oil domestic exports situation.

Moody’s Analytics says that the global shift away from PCs is hurting Singapore’s tech producers, as are more cost-effective and larger-scale producers elsewhere in the region.

Singapore’s manufactured exports continue to diversify away from electronics as exports of semiconductors, disk drives, and other PC components are falling at double-digit year-on-year rates, and this is likely to continue, adds Moody’s Analytics.

Meanwhile, DBS thinks that the manufacturing sector is also weighed down by structural challenges. According to them, domestic restructuring has resulted in a labour crunch, which is crimping export competitiveness and affecting the performance of exports and manufacturing. 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.